Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study.
anti-bacterial agents
clindamycin
dental care
drug utilization
insurance claims analysis
primary health care
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
30 Nov 2022
30 Nov 2022
Historique:
received:
09
11
2022
revised:
23
11
2022
accepted:
25
11
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
(1) Background: Due to increasing antibiotic resistance, the frequency of antibiotic use should be questioned in dentistry and attention paid to the choice of the best suited substance according to guidelines. In Germany, overprescribing of clindamycin was noteworthy in the past. Therefore, the aim of our study was to determine the trend of antibiotic prescriptions in primary dental care. (2) Methods: Prescriptions of antibiotics in German primary dental care from 2017 to 2021 were analysed using dispensing data from community pharmacies, claimed to the statutory health insurance (SHI) funds, and compared with all antibiotic prescriptions in primary care. Prescriptions were analysed based on defined daily doses per 1000 SHI-insured persons per day (DID). (3) Results: Amoxicillin was the most frequently prescribed antibiotic (0.505 DID in 2017, 0.627 in 2021, +24.2%) in primary dental care, followed by clindamycin (0.374 DID in 2017, 0.294 in 2021, -21.4%). Dental prescriptions still made up 56% of all clindamycin prescriptions in primary care in 2021. (4) Conclusions: Our study suggests that the problem of overuse of clindamycin in German dentistry has improved, but still persists.
Identifiants
pubmed: 36551380
pii: antibiotics11121723
doi: 10.3390/antibiotics11121723
pmc: PMC9774256
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Oral Investig. 2016 Nov;20(8):2203-2210
pubmed: 26795626
J Antimicrob Chemother. 2019 Aug 1;74(8):2139-2152
pubmed: 31002336
Br Dent J. 2020 Nov;229(9):601-604
pubmed: 33188343
Schweiz Monatsschr Zahnmed. 2013;123(9):748-59
pubmed: 24114518
Euro Surveill. 2020 Aug;25(31):
pubmed: 32762794
Int Dent J. 2019 Dec;69(6):480-487
pubmed: 31376156
J Craniomaxillofac Surg. 2017 Nov;45(11):1854-1859
pubmed: 28939205
Clin Infect Dis. 2019 Jan 1;68(1):157-164
pubmed: 29986019
Eur J Med Res. 2001 Apr 20;6(4):139-49
pubmed: 11309226
Antibiotics (Basel). 2021 Jul 08;10(7):
pubmed: 34356753
Antimicrob Agents Chemother. 2012 May;56(5):2565-9
pubmed: 22354306
J Dent Res. 2019 Sep;98(10):1081-1087
pubmed: 31314998
Front Microbiol. 2021 Jun 02;12:676108
pubmed: 34149666
Z Evid Fortbild Qual Gesundhwes. 2017 May;122:1-8
pubmed: 28522282
Antimicrob Agents Chemother. 2013 May;57(5):2326-32
pubmed: 23478961
J Am Dent Assoc. 2018 Oct;149(10):869-884.e5
pubmed: 30261952
Am J Med Sci. 2003 Jan;325(1):31-3
pubmed: 12544082
Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1344-1355
pubmed: 30264894
PLoS One. 2017 Nov 14;12(11):e0188061
pubmed: 29136646
Community Dent Oral Epidemiol. 2016 Apr;44(2):145-53
pubmed: 26507098
Antibiotics (Basel). 2021 Aug 16;10(8):
pubmed: 34439037
J Infect Chemother. 2016 May;22(5):319-26
pubmed: 26968486
Implement Sci. 2014 Feb 22;9:27
pubmed: 24559212
Br J Clin Pharmacol. 2021 Jan;87(1):152-162
pubmed: 32436349
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
Allergol Select. 2020 May 28;4:11-43
pubmed: 32568254
BMC Oral Health. 2020 Jun 16;20(1):172
pubmed: 32546149
Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1493-1503
pubmed: 34245078
Clin Microbiol Infect. 2020 Jul;26(7):871-879
pubmed: 31811919